Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Rockwell Medical (RMTI) over the last 6 years, with Sep 2025 value amounting to $36.0 million.

  • Rockwell Medical's Shares Outstanding (Diluted Average) rose 11.12% to $36.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year increase of 11.12%. This contributed to the annual value of $31.1 million for FY2024, which is 33.17% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Shares Outstanding (Diluted Average) is $36.0 million, which was up 4.99% from $34.3 million recorded in Q2 2025.
  • Rockwell Medical's 5-year Shares Outstanding (Diluted Average) high stood at $36.0 million for Q3 2025, and its period low was $8.5 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $28.8 million, with a median of $31.1 million in 2024.
  • Per our database at Business Quant, Rockwell Medical's Shares Outstanding (Diluted Average) slumped by 88.73% in 2021 and then spiked by 116.34% in 2022.
  • Rockwell Medical's Shares Outstanding (Diluted Average) (Quarterly) stood at $8.5 million in 2021, then skyrocketed by 67.77% to $14.3 million in 2022, then soared by 63.05% to $23.3 million in 2023, then surged by 33.17% to $31.1 million in 2024, then climbed by 11.12% to $36.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $36.0 million for Q3 2025, versus $34.3 million for Q2 2025 and $34.1 million for Q1 2025.